A RANDOMIZED, CONTROLLED PHASE 2 CLINICAL TRIAL OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: FINAL DATA Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Heo, Jeong
  • Reid, Tony
  • Ruo, Leyo
  • Bloomston, Mark
  • Lim, Ho Yeong
  • Chung, Hyn Cheol
  • Kim, Chang Won
  • Rose, Steven C
  • Rhee, Byung-Geon
  • Patt, Richard H
  • Lencioni, Riccardo
  • Hickman, Theresa
  • Breitbach, Caroline
  • Moon, Anne
  • Burke, James
  • Bell, John C
  • Hwang, Tae-Ho
  • Kirn, David

publication date

  • October 1, 2011